European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec…
Global biotherapeutics leader CSL Behring announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for etranacogene dezaparvovec…
Read More...
Read More...
